Clinical Trials at NEXT Oncology

As of June 2026, 67 paid clinical trials are recruiting at NEXT Oncology, located at 22151 BULVERDE RD STE 106, SAN ANTONIO, TX 78259-1850, phone (281) 783-8162 in San Antonio, Texas. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

67 clinical trials at NEXT Oncology

·Clear filters·↓ Download CSV

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

for Non Small Cell Lung Cancer

3 locations incl. Boston

Sponsor: Zumutor Biologics Inc.

Sex: All·Age: 18+

Code: NCT06451497·Phase 1·Recruiting

Apply to this trial

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

for Malignant Neoplasm

3 locations incl. Houston

Sponsor: Tyligand Pharmaceuticals (Suzhou) Limited

Sex: All·Age: 18 - 75

Code: NCT06385925·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

9 locations incl. Duarte

Sponsor: AbbVie

Sex: Male·Age: 18+

Code: NCT06318273·Phase 1·Recruiting

Apply to this trial

PAS-004 in Patients With Advanced Solid Tumors

for RAS Mutation

4 locations incl. Austin

Sponsor: Pasithea Therapeutics Corp.

Sex: All·Age: 18+

Code: NCT06299839·Phase 1·Recruiting

Apply to this trial

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

for Metastatic Malignant Neoplasm

6 locations incl. Baltimore

Sponsor: NextPoint Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06240728·Phase 1·Recruiting

Apply to this trial

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for Advanced Solid Tumor

10 locations incl. Denver

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06120283·Phase 1·Recruiting

Apply to this trial

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for Cancer

4 locations incl. Austin

Sponsor: OncoResponse, Inc.

Sex: All·Age: 18+

Code: NCT06090266·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

8 locations incl. Palo Alto

Sponsor: Bristol-Myers Squibb

Sex: Male·Age: 18+

Code: NCT06067841·Phase 1·Recruiting

Apply to this trial

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

for Solid Tumor

3 locations incl. San Antonio

Sponsor: TiumBio Co., Ltd.

Sex: All·Age: 18+

Code: NCT05784688·Phase 1, Phase 2·Recruiting

Apply to this trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for Advanced or Metastatic Solid Tumors

11 locations incl. Scottsdale

Sponsor: Incendia Therapeutics

Sex: All·Age: 18+

Code: NCT05753722·Phase 1·Recruiting

Apply to this trial

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

3 locations incl. Lafayette

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

Sex: All·Age: 18+

Code: NCT05417321·Phase 1, Phase 2·Recruiting

Apply to this trial

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

for Colorectal Cancer

6 locations incl. Encinitas

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT05464030·Phase 1·Recruiting

Apply to this trial

A Study of ASP3082 in Adults With Advanced Solid Tumors

for Solid Tumor

23 locations incl. Duarte

Sponsor: Astellas Pharma Inc

Sex: All·Age: 18+

Code: NCT05382559·Phase 1·Recruiting

Apply to this trial

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for Non-small Cell Lung Cancer (NSCLC)

21 locations incl. Orange

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05379985·Phase 1, Phase 2·Recruiting

Apply to this trial

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

1 location in San Antonio

Sponsor: TiumBio Co., Ltd.

Sex: All·Age: 18+

Code: NCT05204862·Phase 1, Phase 2·Recruiting

Apply to this trial

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for Non-Small Cell Lung Cancer

Drug: Bevacizumab

18 locations incl. Duarte

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05005403·Phase 1·Recruiting

Apply to this trial

Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

10 locations incl. La Jolla

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05007782·Phase 1·Recruiting

Apply to this trial

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

for Advanced or Metastatic Solid Tumor

8 locations incl. Long Beach

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT04617522·Phase 1·Recruiting

Apply to this trial

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

5 locations incl. Duarte

Sponsor: ABL Bio, Inc.

Sex: All·Age: 18+

Code: NCT04762641·Phase 1·Recruiting

Apply to this trial

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

for Solid Tumor, Adult

9 locations incl. San Francisco

Sponsor: Vivace Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT04665206·Phase 1, Phase 2·Recruiting

Apply to this trial

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for Advanced Solid Tumor Cancer

Drug: ABBV-CLS-484

15 locations incl. Tucson

Sponsor: Calico Life Sciences LLC

Sex: All·Age: 18+

Code: NCT04777994·Phase 1·Recruiting

Apply to this trial

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

for Locally Advanced or Metastatic ER+ HER2- Breast Cancer

23 locations incl. Scottsdale

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT04606446·Phase 2·Recruiting

Apply to this trial

Evaluate the Safety and Clinical Activity of HH2853

for FL Lymphoma

4 locations incl. Phoenix

Sponsor: Haihe Biopharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT04390737·Phase 1, Phase 2·Recruiting

Apply to this trial

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

for Cancer

41 locations incl. Tucson

Sponsor: Tizona Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT04485013·Phase 1·Recruiting

Apply to this trial

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for Solid Tumor, Adult

5 locations incl. Los Angeles

Sponsor: BioInvent International AB

Sex: All·Age: 18+

Code: NCT04219254·Phase 1, Phase 2·Recruiting

Apply to this trial

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for Ewing Sarcoma

23 locations incl. Scottsdale

Sponsor: Inhibrx Biosciences, Inc

Sex: All·Age: 12 - 85

Code: NCT03715933·Phase 1·Recruiting

Apply to this trial

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Drug: Mevrometostat

45 locations incl. Tucson

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT03460977·Phase 1·Recruiting

Apply to this trial